Home > Pressemitteilung: The 2025 Else Kröner Fresenius Prize ...

Huntington's disease is a rare and fatal disease characterized ... Massachusetts since 2012. Background to the Else Kröner Fresenius Prize for Medical Research The Else Kröner Fresenius Prize ...

Neurizon Therapeutics Limited, a clinical-stage biotech company dedicated to advancing innovative treatments for ...

PTC Therapeutics, Inc.’s PTCT share price has surged by 6.72%, which has investors questioning if this is right time to sell.

Colossal, a genetics startup, has birthed three pups that contain ancient DNA retrieved from the remains of the animal’s ...

Alnylam Pharmaceuticals, Inc.’s ALNY share price has dipped by 10.08%, which has investors questioning if this is right time to buy.

Central to the probe are DEA's Thomas Prevoznik, DEA's Matthew Strait and DEA attorney Aarathi Haig within the DEA's Diversion Control Division, whose conduct has raised serious questions about the in ...

After losing her husband to ALS, Indu Navar used her tech background to create real change. Learn how she built a data-driven nonprofit to fight ALS and what side hustlers can take from her story.

As the mail-in genetic testing boom continues, sparked by the likes of Chris Hemsworth, experts are warning consumers to ...

Portugal Background Executive dysfunction is one of the major causes of everyday impairments found in Huntington’s disease (HD). Reliable tools to assess and predict the impact of executive ...